Abstract
The Fas/APO-1(CD95) cell surface receptor binds to the Fas ligand, leading to apoptotic cell death under a variety of pathological conditions. In viral myocarditis, a perforin-based mechanism involving killer cells is known to play a role in necrotic myocardial injury. However, little is known about apoptotic cell death in myocarditis. Serum levels of the soluble form of Fas and Fas ligand were much higher in patients with myocarditis than in other cardiac patients. There was a positive correlation between sIL-2R and sFas levels in patients with myocarditis. In the myocarditis group, sFasligand levels increased with the severity of heart failure, as defined by New York Heart Association functional class. Cardiac tissues from rats with autoimmune myocarditis showed in situ DNA fragments by DNA laddering formation and TUNEL assay, the biological hallmark of apoptosis, in some cardiomyocytes and infiltrating lymphocytes. The expression of Fas ligand was up-regulated in some cardiomyocytes and lymphocytes. Fas ligand mRNA and protein were expressed in some CD4+ T cells. Coexpression of Fas with the Fas ligand was observed in some infiltrating lymphocytes. Furthermore, when cultured neonatal cardiomyocytes were exposed to the soluble form of Fas ligand in the presence of actinomycin D, the cells underwent apoptotic cell death, as demonstrated by electron microscopy, flow cytometry, and the TUNEL assay. These results suggest that some portion of the cardiomyocytes and infiltrating lymphocytes are subjected to apoptotic cell death, possibly due to T cell-mediated cytotoxicity, which is modulated by the Fas/Fas ligand pathway in myocarditis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sekiguchi M, Hiroe M, Take M, Hirosawa K (1980) Clinical and histopathological profile of the sarcoidosis of heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy II. Myocarditis. Jpn Circ J 44: 264–273
Hiroe M, Sekiguchi M, Take M, Matsuda M, Hirosawa K (1985) Hemodynamic studies and response to a combined therapy of nitroglycerin ointment and dopamine in patients with acute myocarditis. Heart Vessels Suppl 1: 180–186
Hiroe M, Sekiguchi M, Take M, Kusakabe K, Shigeta A, Hirosawa K (1985) Long follow-up study in patients with prior myocarditis by radionuclide methods. Heart Vessels Suppl 1: 199–203
Dec GW, Alacios IF, Fallon JT, Artez HT, Mills J, Lee DC, Johnson RA (1985) Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome. N Engl J Med 312: 885–890
Fenoglio JJ, Ursell PC, Kellogg CF, Drusin RE, Weiss MB (1983) Diagnosis and classification of myocarditis by endomyocardial biopsy. N Engl J Med 308: 112–118
Aretz JT (1987) Myocarditis: the Dallas criteria. Hum Pathol 18: 619–635
Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL (1991) Clinico-pathologic description of myocarditis. J Am Coll Cardiol 18: 1617–1626
Woodruff JF (1980) Viral myocarditis: a review. Am J Pathol 101: 427–484
Bowles NE, Richardson Pi Olsen EGJ,Archard LC (1986) Detection of Coxsackie-Bvirus specific RNA sequence in myocardial biopsy sample from patients with myocarditis and dilated cardiomyopathy. Lancet 1: 1120–1123
Jin O, Sole M, Butany J (1990) Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using polymerase chain reaction. Circulation 82: 8–16
Martin AB, Webber S, Fricker J, Jaffe R, Demmler G, Kearney D, Zhang Y-H, Bodurtha J, Gelb B, Ni J, Bricker T, Towbin JA (1994) Acute myocarditis: rapid diagnosis by PCR in children. Circulation 90: 330–339
Berke G (1995) The CTL’s kiss of death. Cell 81: 9–12
Liu CC, Young LHY, Young JDE (1996) Lymphocyte-mediated cytolysis and disease. N Engl J Med 335: 1651–1659
Kâgi D, Vignaux F, Ledeman B, Burki K, Depraetere V, Nagata S, Hengarttner H. Golstein P (1994) Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265: 528–530
Young JD, Hengartner H, Podack ER, Cohn ZA (1986) Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity. Cell 44: 849–859
Shi L, Kam C-M, Powers JC, Aebersold R, Greenberg AH (1992) Purification of three cytotoxic lymphocytes granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med 176: 1521–1529
Arase H, Arase N, Saito S (1995) Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 181: 1235–1238
Nagata S (1997) Apoptosis by death factor. Cell 88: 355–365
Krammer PH, Dhein J, Walczak H, Behrmann I, Mariani S, Matiba B, Fath M, Daniel PT, Knipping E, Westendorp MO, Stricker K, Baumler C, Hellbardt S, Germer M, Peter ME, Debatin K-M (1994) The role of APO-1 mediated apoptosis in the immune system. Immunol Rev 142: 175–191
Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239–257
Li Y, Sharov VG, Jiang N, Zaloga C, Sabbah HN, Chopp M (1995) Ultrastructual and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat. Am J Pathol 146: 1045–1051
Majino G, Joris I (1995) Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol 146: 3–15
Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous nuclease activation. Nature 284: 555–556
Wyllie AH, Morris RG, Smith AL, Dunlop D (1984) Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macro-molecular synthesis. J Pathol 142: 67–77
Raff MC (1992) Social control on cell survival and cell death. Nature 356: 397–400
Thompson CB (1995) Apoptosis in the pathogenesis and treatment of diseases. Science 267: 1456–1462
Feuerstein G, Rufflo RR Jr, Yue TL (1997) Apoptosis and congestive heart failure. Trends Cardiovasc Med 7: 249–255
MacLellan WR, Schneider MD (1997) Death design: programmed cell death in cardiovascular biology and disease. Circ Res 81: 137–144
Haunstetter A, Izumo S (1998) Apoptosis: basic mechanisms and implications for cardiovascular diseases. Circ Res 82: 1111–1126
Anversa P, Leri A, Beltrami CA, Guerra S, Kajstura J (1998) Myocyte death and growth in the failing heart. Lab Invest 78: 767–786
Sabbah H, Sharov VG (1998) Apoptosis in heart failure. Prog Cardiovasc Dis 40: 549–562
Kajstura J, Mansukhan IM, Cheng W, Reis Anversa P (1995) Programmed cell death and the expression of the protooncogene Bel-2 in myocyte during postnatal maturation of the heart. 219: 110–121
Takeda K, Yu ZX, Nishikawa T, Tanaka M, Hosoda S, Ferrans VJ, Kasajima T (1996) Apoptosis and DNA fragmentation in the bulbus cordis of the developing rat heart. J Mol Cell Cardiol 28: 209–215
Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw B-A (1996) Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335: 1182–1189
Olivetti JT, Abbi R, Quaini F, Kajstura J, Cheng W, Wuaini E, Loreto CD, Beltrrrami CA, Krajewski S, Reed JC, Anversa P (1997) Apoptosis in failing human heart. N Engl J Med 336: 1131–1141
Liu Y, Cigola E, Cheng E, Kajstura J, Olivetti G, Hintze TH, Anversa P (1995) Myocyte nuclear mitotic division and programmed cell death characterize the cardiac myopathy induced by rapid right ventricular pacing in dogs. Lab Invest 73: 771–787
Sharov VG, Sabbah HN, Shimoyama H, Goussev AV, Lesch M, Goldstein S (1996) Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 148: 141–149
Bing OHL (1994) Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload. J Mol Cell Cardiol 26: 943–948
Itoh G, Tamura J, Suzuki M, Suzuki Y, Ikeda H, Koike M, Nomura M, Jie T, Ito K (1995) DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol 146: 1325–1331
Saraste AK, Pulkki K, Henrikesen M, Parvinen M, Voipio-Pulkki L-M (1997) Apoptosis in human acute myocardial infarction. Circulation 95: 320–323
Gottlieb RA, Burleson KO. Kloner RA, Bablor BM, Engler RL (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621–1628
Fliss H, Gattinger D (1996) Apoptosis in ischemic and reperfused rat myocardium. Circ Res 79: 949–956
Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P (1996) Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 74: 86–107
Fliss H, Gattinger D (1996) Apoptosis in ischemia and reperfused rat myocardium. Circ Res 79: 949–956
Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G (1996) Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 335: 1190–1196
Valente M, Calabrese F, Thiene G. Angnelini A, Basso C, Nava A, Rossi L (1998) In vivo evidence of apoptosis in arrhythmogenic right ventricular cardio-myopathy. Am J Pathol 132: 479–484
James TN, Nichols MM, Sapire DW, DiPatre PL, Lopez SM (1996) Complete heart block and fatal right ventricular failure in an infant. Circulation 93: 1588–1600
Diez J, Panizo A, Hernandez M, Vega F. Sola I, Fortufio MA, Pardo J (1997) Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension 30: 1029–1034
Frusutaci A, Chimenti C, Setoguchi M, Guerra S, Corsello S, Crea F, Len A, Kajstura J, Anversa P, Maseri A (1999) Cell death in acromegalic cardiomyopathy. Circulation 99: 1426–1434
Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo H, Hiroe M (1994) Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 75: 426–433
Laderoute KR, Webster KA (1997) Hypoxia/reoxygenation stimulate Jun kinase activity through redox signaling in cardiac myocytes. Circ Res 80: 336–344
Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P (1995) Stretch-induced programmed myocyte cell death. J Clin Invest 96: 2247–2259
Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJE, Sabbadini RA (1996) Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98: 2854–2856
Kajstura J, Cigola E, Malhotra A, Cheng W, Meggs LG, Anversa P (1997) Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 29: 859–870
Wu CF, Bishopric NH, Pratt RE (1997) Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem 272: 14860–14866
Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M, Shiojima I, Hiroi Y, Yazaki Y (1997) Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 100: 1813–1821
Shimojo T, Hiore M, Ishiyama S, Ito H, Nishikawa T, Marumo F (1999) Nitric oxide induces apoptotic death of cardiomyocytes via a cyclic-GMP-dependent pathway. Exp Cell Res 247: 38–47
Watanabe FR, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S (1992) The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148: 1274–1279
Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233–243
Yonehara S, Ishi A, Yonehara M (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169: 1747–1756
Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364: 306–309
Suda T, Nagata S (1994) Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 179: 873–879
Dhein J, Walczak H, Bâumler C, Debatin KM, Krammer PH (1995) Autocrine T-cell suicide mediated by Apo-1/Fas/CD95. Nature 373: 438–441
Ju S-T, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, MarshakRothstein A (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373: 444–448
Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263: 1759–1762
Liu C, Cheng J, Mountz JD (1995) Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. Biochem J 310: 957–963
Papoff G, Cascino I, Eramo A, Starace G, Lynch DH, Ruberti G (1996) An N-terminal domain shared by Fas/Apo-1(CD95) soluble variants prevents cell death in vitro. J Immunol 156: 4622–4630
Nishigaki K, Minatoguchi S, Seishima M, Asano K, Noda T, Yasuda N, Sano H, Kumada H, Takemura M, Noma A, Tanaka T, Watanabe S, Fujiwara H (1997) Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol 29: 1214–1220
Okuyama M, Yamaguchi S, Nozaki N, Yamaoka M, Shirakabe M, Tomoike H (1997) Serum levels of soluble form of Fas molecule in patients with congestive heart failure. Am J Cardiol 79: 1698–1701
Toyozaki T, Hiroe M, Saito T, Iijima Y. Takano H, Hiroshima K, Kohno H, Ishiyama S, Marumo F, Masuda Y, Ohwada H (1998) Levels of soluble Fas in patients with myocarditis, heart failure of unknown origin, and in healthy volunteers. Am J Cardiol 81: 798–800
Kayagaki N, Kawasaki A, Ebata T. Ohmoto H, Ikeda S, Inoue S, Yoshini K, Nozawa K, Okuyama K, Yagita H (1995) Metalloproteinase-mediated release of human Fas ligand. J Exp Med 182: 1777–1783
Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummoud AH, Nagata S (1996) Fas ligand in human serum. Nature Med 2: 317–322
Nozawa K, Kayagaki N,Tokano Y, Yagita H, Okumura K, Hashimoto H (1997) Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases. Arthritis Rheum 40: 1126–1129
Tanaka M, Suda T, Takahashi T, Nagata S (1995) Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 14: 1129–1135
Toyozaki T, Hiroe M, Tanaka M, Nagata S, Ohwada H, Marumo F (1998) Levels of soluble Fas ligand in myocarditis. Am J Cardiol 82: 246–248
Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW (1987) Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 139: 3630–3636
Smith SC, Allen PM (1991) Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol 147: 2141–2147
Kodama M, Matsumoto Y, Fujiwara M (1992) In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation 85: 1918–1926
Ishiyama S, Hiroe M, Nishikawa T, Abe S, Shimojo T, Ito H, Ozasa S, Yamakawa K, Matsuzaki M, Mohammed MU, Nakazawa H, Kasajima T, Marumo F (1997) Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation 95: 489–496
Davidoff R, Palacios I, Southern J, Fallon JT, Newell J, Dec GW (1991) Giant cell versus lymphocytic myocarditis: a comparison of their clinical features and long-term outcomes. Circulation 83: 953–961
Ishiyama S, Hiroe M, Nishikawa T, Shimojo T, Abe S, Fujisaki H, Ito H, Yamakawa K, Kobayashi N, Kasajima T, Marumo F (1998) The Fas/Fas ligand system is involved in the pathogenesis of autoimmune myocarditis in rats. J Immunol 161: 4695–4701
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Tokyo
About this paper
Cite this paper
Hiroe, M., Toyozaki, T. (2000). Pathogenesis of Myocardial Injury and Cell Death in Myocarditis: Its Relation to the Fas/Fas Ligand Pathway. In: Kitabatake, A., Sasayama, S., Francis, G.S., Okamoto, H. (eds) Heart Failure. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68331-5_5
Download citation
DOI: https://doi.org/10.1007/978-4-431-68331-5_5
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68333-9
Online ISBN: 978-4-431-68331-5
eBook Packages: Springer Book Archive